Eric F. Johnson

14.6k citations
153 papers · 10.0k · 5 hit papers · h-index 44

Impact in

  • Pharmacology top 0.05%
    • Pharmacogenetics and Drug Metabolism
  • Oncology top 0.5%
    • Drug Transport and Resistance Mechanisms
    • PARP inhibition in cancer therapy

Papers in

    • DNA Repair Mechanisms 10
    • Biochemical and Molecular Research 9
    • PI3K/AKT/mTOR signaling in cancer 9
    • Cancer therapeutics and mechanisms 8
    • PARP inhibition in cancer therapy 18
    • HER2/EGFR in Cancer Research 7

Eric F. Johnson

148 papers receiving 9.8k citations

Eric F. Johnson's Hit Papers

ABC transporters: the power to change 2009 · 1.1k citations
1.1k0+13+26Years since publication50010001.5k

Peers

Eric F. Johnson
Comparison fields: 5 of 169
  • Pharmacology 1.9k
  • Oncology 2.8k
  • Molecular Biology 4.9k
  • Biochemistry 454
  • Cancer Research 578
Replace Anne Monks with:
Anne Monks United States
Balázs Sarkadi Hungary
Ann M. Bode United States
Suresh V. Ambudkar United States
Ruth Roberts United Kingdom
Lijuan Chen China
Md. Imtaiyaz Hassan India
Tommy Andersson Sweden
André Guillouzo France
Hiroyuki Osada Japan
Eric F. Johnson relative to Anne Monks United States Anne Monks's profile →
Citations per field
00.5×1.5×1.8×
Anne Monks · 1×
Citations per year

Countries citing papers authored by Eric F. Johnson

Since Specialization
Citations

This map shows the geographic impact of Eric F. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric F. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric F. Johnson more than expected).

Fields of papers citing papers by Eric F. Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric F. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric F. Johnson. The network helps show where Eric F. Johnson may publish in the future.

Co-authors

The 25 scholars most cited alongside Eric F. Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eric F. Johnson Line = papers co-authored together Eric F. Johnson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 153 papers — load more, or switch the sort, to bring in the rest.

#Work
1
ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
Hit paper breakdown →
20081535
2
ABC transporters: the power to change
Hit paper breakdown →
20091096
3
The P450 Superfamily: Update on New Sequences, Gene Mapping, and Recommended Nomenclature
Hit paper breakdown →
1991903
4
The P450 Gene Superfamily: Recommended Nomenclature
Hit paper breakdown →
1987660
5
The P450 Superfamily: Updated Listing of All Genes and Recommended Nomenclature for the Chromosomal Loci
Hit paper breakdown →
1989520
6 1989272
7 2003240
8 2011238
9 2008218
10 2015205
11 2008181
12 2018179
13 2015174
14 2011139
15 1988132
16 2005112
17 200999
18 201195
19 200994
20 200791

About Eric F. Johnson

Eric F. Johnson is a scholar working on Molecular Biology, Oncology, Mechanics of Materials, Pharmacology and Organic Chemistry, having authored 153 papers that have together received 10.0k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (18 papers), Pharmacogenetics and Drug Metabolism (14 papers), Mechanical Behavior of Composites (14 papers), DNA Repair Mechanisms (10 papers), Biochemical and Molecular Research (9 papers), PI3K/AKT/mTOR signaling in cancer (9 papers), Cancer therapeutics and mechanisms (8 papers) and HER2/EGFR in Cancer Research (7 papers). The work is most often cited by research in Pharmacology (1.9k citations), Oncology (2.8k citations), Molecular Biology (4.9k citations), Biochemistry (454 citations) and Cancer Research (578 citations). Eric F. Johnson has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Douglas C. Rees, Oded Lewinson, Michael R. Waterman, Ryo Sato, Minor J. Coon, I. C. Gunsalus, F. Peter Guengerich, Ronald W. Estabrook, Daniel W. Nebert and Frank J. Gonzalez. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Biological Chemistry, Biochemistry, Journal of Medicinal Chemistry and Molecular Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact